Wappingers Falls, NY, United States of America

Umer Sayeed-Shah

This inventor holds 1 USPTO granted patent. Top assignee: The Brigham and Women's Hospital, Inc.. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Umer Sayeed-Shah: Innovator in Injury-Mediated Therapy and Drug Delivery

Introduction

Umer Sayeed-Shah is a notable inventor based in Wappingers Falls, NY (US). He has made significant contributions to the field of medical technology, particularly in the area of injury-mediated therapy and drug delivery. His innovative approach aims to enhance the treatment of diseases such as coronary artery disease.

Latest Patents

Umer Sayeed-Shah holds a patent for a method and apparatus for combining injury-mediated therapy and drug delivery. This patent describes a method of enhancing injury-induced revascularization of tissue as a treatment for diseases. The method involves creating an injury in a tissue, such as cardiac muscle, using techniques like lasers, ultrasonic devices, or thermal probes. Following this, a revascularization-promoting molecule or a nucleic acid molecule encoding such a molecule is injected into the tissue. The patent also details an apparatus that can be utilized to practice this method.

Career Highlights

Umer Sayeed-Shah is affiliated with The Brigham and Women's Hospital, Inc., where he continues to work on innovative medical solutions. His research focuses on improving therapeutic outcomes for patients suffering from cardiovascular diseases.

Collaborations

Umer has collaborated with esteemed colleagues, including Michael J Mann and Victor J Dzau, to advance his research and develop effective treatment methodologies.

Conclusion

Umer Sayeed-Shah's contributions to the field of medical technology through his innovative patent demonstrate his commitment to improving patient care. His work in injury-mediated therapy and drug delivery is paving the way for new treatment options in cardiovascular medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…